1964 related articles for article (PubMed ID: 9151012)
1. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
Plum J; Mirzaian Y; Grabensee B
Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
[TBL] [Abstract][Full Text] [Related]
3. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
4. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
5. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
6. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
7. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration].
Ando M
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568
[TBL] [Abstract][Full Text] [Related]
8. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
Nielsen CB; Pedersen EB
Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
[TBL] [Abstract][Full Text] [Related]
9. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
[TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of water metabolism in children with nephrotic syndrome.
Rascher W; Tulassay T
Kidney Int Suppl; 1987 Aug; 21():S83-9. PubMed ID: 3306110
[TBL] [Abstract][Full Text] [Related]
11. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
12. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
14. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
Minutolo R; Andreucci M; Balletta MM; Russo D
Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
[TBL] [Abstract][Full Text] [Related]
15. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Paulsen L; Holm C; Bech JN; Starklint J; Pedersen EB
Nephrol Dial Transplant; 2008 May; 23(5):1556-61. PubMed ID: 18065809
[TBL] [Abstract][Full Text] [Related]
16. Renal response to atrial natriuretic peptide in nephrotic syndrome.
Rabelink AJ; Koomans HA; Gaillard CA; Dorhout Mees EJ
Nephrol Dial Transplant; 1987; 2(6):510-4. PubMed ID: 2964567
[TBL] [Abstract][Full Text] [Related]
17. Renal actions of theophylline and atrial natriuretic peptide in humans: a comparison by means of clearance studies.
Beutler JJ; Koomans HA; Bijlsma JA; Dorhout Mees EJ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1314-9. PubMed ID: 2148189
[TBL] [Abstract][Full Text] [Related]
18. Glomerular and tubular antinatriuretic actions of low-dose angiotensin II infusion in man.
Eiskjaer H; Sørensen SS; Danielsen H; Pedersen EB
J Hypertens; 1992 Sep; 10(9):1033-40. PubMed ID: 1328362
[TBL] [Abstract][Full Text] [Related]
19. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
20. [Atrial natriuretic peptide in children with nephrotic syndrome].
Jovanovitsh O; Popovitsh-Rolovitsh M; Radoshevitsh P; Stankovitsh R; Dujitsh A; Gajitsh M; Peco-Antitsh A; Krushchitsh D; Kostitsh M
Srp Arh Celok Lek; 1995; 123(11-12):291-4. PubMed ID: 16296241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
